UnknownNot Applicable

OCT and OCT-A Afer Diabetic Vitrectomy in PDR

30 participantsStarted 2023-08-01

Plain-language summary

Detection of any structural or vascular changes at the macula after Pars Plana Vitrectomy ( PPV ) in cases with complicated proliferative diabetic retinopathy ( PDR )

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cases with complicated PDR as persistant vitreous hemorrhage or tractional retinal detachment involving or threatening the macula underwent PPV with or without ILM peeling Exclusion Criteria: * eyes with media opacity after PPV not allowing imaging of the macula

What they're measuring

OCT and OCT angiography to assess the macular thickness , outline and vascularity

Timeframe: 3 months after surgery

Trial details

NCT IDNCT05938491

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-01

Contact for this trial

Omar Abdelkarem Hasan, M.B.B.CH

00201000525341 oabdelkarem@gmail.com

View on ClinicalTrials.gov More Proliferative Diabetic Retinopathy trials